On the materials and delivery front, recent reviews and studies of PLGA nanomedicines highlight robust strategies for mucosal delivery, barrier crossing, and integration of diagnostics with targeted payload release
As one pharmaceutical review noted, "the activation of pro-migratory signals and pro-angiogenic factors by BPC-157 is a double-edged sword." No studies have proven that BPC-157 causes cancer, but the biological plausibility of this concern cannot be dismissed
And I think frailty Sarcopenia is the term where that inflammaging or inflammation process, that metabolic dysfunction starts to literally create a pathology in our muscles and we start to waste
Researchers use it to study metabolism, brain signals, and appetite control
Those are two different starting points with very different endpoint lengths
Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies